HENDERSON JANE (Chief Financial Officer) sold 1.1% of their position (2K shares) of APOGEE THERAPEUTICS, INC. on the open market
Open‑market sale worth $170.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/3/2026ACC: 0001104659-26-039708
Officer· Chief Financial Officer
Since Mar 2026
-2K
Net shares
Net seller
$170.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−900.00
Price / share
$84.46
Trade value
$76.01K
% of position
0.5%
4/1/2026
179.37K→178.47K
Common Stock
Direct
Shares
−1.10K
Price / share
$85.46
Trade value
$94.01K
% of position
0.6%
4/1/2026
178.47K→177.37K
Total
Net shares
−2K
Net value
-$170.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | S · Sale | −900.00 | $84.46 | $76.01K | 0.5% | 179.37K | 178.47K |
| Common Stock Direct | 4/1/2026 | S · Sale | −1.10K | $85.46 | $94.01K | 0.6% | 178.47K | 177.37K |
| Total | −2K | -$170.02K | ||||||
Derivative Transactions0
No derivative transactions reported